Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / ...

According to SNS Insider, the global Cell Line Development Market was valued at USD 5.46 billion in 2023 and is projected to reach USD 12.56 billion by 2032, expanding at a CAGR of 9.66% from ...

Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...

Genetic variation affects the expression of genes and function of proteins. DNA sequencing technologies have uncovered millions of genetic changes associated with various human traits and disease.

2022年7月7日に、QYResearchは「グローバル安定したセルラインの開発製品に関する市場レポート, 2017年-2028年の推移と予測、会社別、地域別、製品別、アプリケーション別の情報」の調査資料を発表しました。安定したセルラインの開発製品の市場生産能力 ...

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO cell line development (CLD) platform with the launch of two ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...